Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioAlliance, Teva sign licensing agreement for Sitavig in Israel
The agreement included upfront and milestone payments as well as royalties on sales in Israel, to be paid to BioAlliance by Teva. Financial terms of the license agreement
The agreement included upfront and milestone payments as well as royalties on sales in Israel, to be paid to BioAlliance by Teva. Financial terms of the license agreement
Abbott also uses another pharma cloud-based mobile solution OneKey designed to improve targeting and segmentation. The technology powered by Onekey will help Abbott’s Epidemiology, Immunology,Market Access,Medical and Specialty
The drug, which is used to treat sickle cell disease, increases the oxygenation properties of red blood cells by reducing their oxygen-hemoglobin affinity and allowing them to release
The platform is used for mining clinical trials data for decision support in biomedical research, clinical trials study design, site selection and competitive intelligence. The solution is also
As part of the agreement, Full Spectrum Genetics protein analysis and engineering platform, MapEng, and BioBlocks’ fragment based drug discovery platform technology,Fragment-to-Lead, will be combined. The technologies will
The research will focus on data originating from biotechnology companies,academia and from internal research projects. The studies will be carried out from Type 1 Diabetes R&D Center of
In collaboration with Bayer HealthCare, Genzyme is developing lemtrada in MS. Genzyme President and CEO David Meeker said, "There remains a large unmet treatment need for patients living
The all-cash transaction is expected to expand Amgen’s presence in Turkey and the surrounding region. The acquisition was initially announced on 25 April 2012. MN Pharmaceuticals, a manufacturer
As part of the agreement Polyphor will use its MacroFinder drug discovery technology to identify and optimize macrocyclic drug candidate addressing therapeutic targets selected by Boehringer. Boehringer will
A vegetarian and sustainable source was used in DHA, a polyunsaturated omega-3 fatty acid found throughout the body, in the human studies. The DHA is a major structural